172 related articles for article (PubMed ID: 22543885)
1. The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
Clark PJ; Thompson AJ; Zhu Q; Vock DM; Zhu M; Patel K; Harrison SA; Naggie S; Ge D; Tillmann HL; Urban TJ; Shianna K; Fellay J; Goodman Z; Noviello S; Pedicone LD; Afdhal N; Sulkowski M; Albrecht JK; Goldstein DB; McHutchison JG; Muir AJ
Dig Dis Sci; 2012 Aug; 57(8):2213-21. PubMed ID: 22543885
[TBL] [Abstract][Full Text] [Related]
2. PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C.
Ampuero J; Del Campo JA; Rojas L; García-Lozano JR; Solá R; Andrade R; Pons JA; Navarro JM; Calleja JL; Buti M; González-Escribano MF; Forns X; Diago M; García-Samaniego J; Romero-Gómez M
Ann Hepatol; 2014; 13(4):356-63. PubMed ID: 24927606
[TBL] [Abstract][Full Text] [Related]
3. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
Scheiner B; Mandorfer M; Schwabl P; Payer BA; Bucsics T; Bota S; Aichelburg MC; Grabmeier-Pfistershammer K; Stättermayer A; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T
PLoS One; 2015; 10(11):e0143429. PubMed ID: 26599080
[TBL] [Abstract][Full Text] [Related]
4. TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.
Petta S; Maida M; Grimaudo S; Pipitone RM; Macaluso FS; Cabibi D; Cammà C; Di Marco V; Sferrazza S; Craxì A
Liver Int; 2016 Feb; 36(2):198-204. PubMed ID: 26259026
[TBL] [Abstract][Full Text] [Related]
5. Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor.
Moritou Y; Ikeda F; Iwasaki Y; Baba N; Takaguchi K; Senoh T; Nagano T; Takeuchi Y; Yasunaka T; Ohnishi H; Miyake Y; Takaki A; Nouso K; Yamamoto K
Acta Med Okayama; 2014; 68(1):17-22. PubMed ID: 24553484
[TBL] [Abstract][Full Text] [Related]
6. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
Stättermayer AF; Rutter K; Beinhardt S; Scherzer TM; Stadlmayr A; Hofer H; Wrba F; Steindl-Munda P; Krebs M; Datz C; Trauner M; Ferenci P
J Hepatol; 2012 Sep; 57(3):492-8. PubMed ID: 22634340
[TBL] [Abstract][Full Text] [Related]
7. Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin.
Valenti L; Aghemo A; Stättermayer AF; Maggioni P; De Nicola S; Motta BM; Rumi MG; Dongiovanni P; Ferenci P; Colombo M; Fargion S
Aliment Pharmacol Ther; 2012 Jun; 35(12):1434-42. PubMed ID: 22530607
[TBL] [Abstract][Full Text] [Related]
8. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis.
Cai T; Dufour JF; Muellhaupt B; Gerlach T; Heim M; Moradpour D; Cerny A; Malinverni R; Kaddai V; Bochud M; Negro F; Bochud PY
J Hepatol; 2011 Sep; 55(3):529-535. PubMed ID: 21236304
[TBL] [Abstract][Full Text] [Related]
9. Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3.
Rembeck K; Alsiö A; Christensen PB; Färkkilä M; Langeland N; Buhl MR; Pedersen C; Mørch K; Westin J; Lindh M; Hellstrand K; Norkrans G; Lagging M
PLoS One; 2012; 7(1):e29370. PubMed ID: 22253715
[TBL] [Abstract][Full Text] [Related]
10. Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus.
Wong GL; Chan HL; Tse CH; Chan PO; Cheng JC; Cheng JS; Lau SH; Lee EK; Ma JM; Chan AW; Choi PC; Wong VW
J Gastroenterol Hepatol; 2015 Jun; 30(6):1040-8. PubMed ID: 25639146
[TBL] [Abstract][Full Text] [Related]
11. IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection.
Lin CY; Chen JY; Lin TN; Jeng WJ; Huang CH; Huang CW; Chang SW; Sheen IS
PLoS One; 2011 Mar; 6(3):e18322. PubMed ID: 21479134
[TBL] [Abstract][Full Text] [Related]
12. Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response.
Gavril OI; Arhire LI; Gavrilescu O; Dranga M; Barboi O; Gavril RS; Popescu R; Cijevschi Prelipcean C; Trifan AV; Mihai C
Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833371
[No Abstract] [Full Text] [Related]
13. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease.
Petta S; Grimaudo S; Cammà C; Cabibi D; Di Marco V; Licata G; Pipitone RM; Craxì A
J Hepatol; 2012 Jun; 56(6):1356-62. PubMed ID: 22314430
[TBL] [Abstract][Full Text] [Related]
14. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
[TBL] [Abstract][Full Text] [Related]
15. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
Mueller JL; King LY; Johnson KB; Gao T; Nephew LD; Kothari D; Simpson MA; Zheng H; Wei L; Corey KE; Misdraji J; Lee JH; Lin MV; Gogela NA; Fuchs BC; Tanabe KK; Gordon FD; Curry MP; Chung RT
Clin Transplant; 2016 Apr; 30(4):452-60. PubMed ID: 26854475
[TBL] [Abstract][Full Text] [Related]
16. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.
Petta S; Rosso C; Leung R; Abate ML; Booth D; Salomone F; Gambino R; Rizzetto M; Caviglia P; Smedile A; Grimaudo S; Cammà C; Craxì A; George J; Bugianesi E
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):311-7.e1. PubMed ID: 23220171
[TBL] [Abstract][Full Text] [Related]
17. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
[TBL] [Abstract][Full Text] [Related]
18. Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
Tillmann HL; Patel K; Muir AJ; Guy CD; Li JH; Lao XQ; Thompson A; Clark PJ; Gardner SD; McHutchison JG; McCarthy JJ
J Hepatol; 2011 Dec; 55(6):1195-200. PubMed ID: 21703198
[TBL] [Abstract][Full Text] [Related]
19. The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis.
Magri MC; Manchiero C; Prata TVG; Nunes AKDS; Oliveira Junior JS; Dantas BP; Tengan FM
Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115025. PubMed ID: 32147132
[TBL] [Abstract][Full Text] [Related]
20. IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection.
Taliani G; Spaziante M; Biliotti E; Borro M; Palazzo D; Grieco S; Franchi C; Iaiani G; Furlan C; Gallinaro V; Simmaco M
PLoS One; 2013; 8(8):e67301. PubMed ID: 23936294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
